Nuclear Medicine Imaging Equipment Market Analysis | 2021-2026

Market Insights

The Nuclear Medicine Imaging Equipment Market is projected to grow from USD 2.8 billion in 2020 to USD 3.7 billion by 2026 at a CAGR of around 4.9% during the forecast period.

Wish to get a free sample? Register Here

What is nuclear imaging?

Nuclear imaging can be defined as an emerging imaging technology that utilizes a small quantity of radioactive substance associated with compounds used by the compounds of the body which link to tumor cells. The radioactive tracer can be placed in the body to detect, where and when they concentrate. Based on type, nuclear medicine imaging equipment can be categorized as SPECT systems, hybrid PET systems, and planar scintigraphy.

Key Players

Key players operating in the Nuclear Medicine Imaging Equipment market are-

• Digirad Corp. (US)
• GE Healthcare Plc (UK)
• Mediso Medical Imaging Systems (Hungary)
• Philips Healthcare (US)
• Positron Corporation (US)
• Siemens Healthineers (Germany)
• DDD-Diagnostic A/S (Denmark)
• CMR Naviscan Corporation (US)
• Surgiceye GmbH (Germany)
• Canon Medical Systems Corporation (Japan)
• Neusoft Medical Systems Co., Ltd. (China).

Market Dynamics

The growth of the nuclear medicine imaging equipment market is primarily driven by rising incidences of cancer and cardiovascular diseases across geographies. The growing usage of nuclear medicine to diagnose diseases including thyroid-related diseases, respiratory diseases, bone diseases, and neurological diseases is likely to drive the market growth at a significant rate during the review period. In addition to this, surging demand for advanced diagnostic tools is likely to create lucrative opportunities for the players operating in the global nuclear medicine imaging equipment market in the coming years.

COVID-19 Impact

The covid-19 outbreak posed significant challenges across verticals worldwide. It impacted the growth of the nuclear medicine imaging equipment market negatively as the diagnostic procedures declined and PET/CT scans decreased or canceled due to fear of coronavirus infection. Also, supply chain disruptions due to the imposition of lockdown affected the product availability on time and thus, affected the market growth.

To get the full scope of the report, Register Here

Segment Analysis

Application Trends

The nuclear medicine imaging equipment market has been bifurcated into oncology, cardiology, and others. The cardiology segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period. The segment can be attributed to increasing product use in evaluating coronary heart disease (CHD) and cardiomyopathy.

Regional Analysis

The North American market accounted for the largest market share in 2020 and is projected to grow at a robust CAGR during the review period. This can be attributed to the growing emphasis on the adoption of advanced diagnostic tools in the healthcare industry coupled with the presence of key market players such as Digirad Corp. (US) and Philips Healthcare (US). The market growth in Asia-Pacific is expected to be driven by an increasing number of people suffering from cancer and heart-related diseases in developing countries particularly China and India.

To know which region offers the best growth opportunities? Register Here

Target Audience

Here is the list of the group of customers that the market hopes to have the greatest opportunity to convert-

• Distributors
• Suppliers
• Manufacturers
• Logistics organizations
• Government bodies

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

What deliverables will you get in this report?

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to three players)
• SWOT analysis of key players (up to three players)

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.